Researchers are studying the cellular origin and early evolution of leukemia in individuals with Down syndrome. The studies involve analyzing the genomic and epigenetic landscape of leukemia cells, including the use of single-cell multiomics analysis to understand the development and progression of the disease. Findings may shed light on the mechanisms of leukemogenesis and potentially inform treatment approaches.